³Ô¹Ï±¬ÁÏ

Skip to content
Contact Sales 866-417-3024

Regions

North America

Europe

EN | DE | ES | FR | IT

°ä³ó¾±²Ô²¹&²Ô²ú²õ±è;Öйú

´³²¹±è²¹²Ô&²Ô²ú²õ±è;ÈÕ±¾

Asia Pacific

Korea

Latin America

PORTUGUESE | SPANISH

Industries

Life Sciences

MedTech

³Ô¹Ï±¬ÁÏ Logo
  • ³Ô¹Ï±¬ÁÏ
    • Clinical Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ Clinical Platform
      • Clinical Operations
      • ³Ô¹Ï±¬ÁÏ eTMFStay inspection ready
      • ³Ô¹Ï±¬ÁÏ CTMSManage trials end-to-end
      • ³Ô¹Ï±¬ÁÏ PaymentsPay clinical research sites faster
      • ³Ô¹Ï±¬ÁÏ Study StartupAccelerate site activation
      • ³Ô¹Ï±¬ÁÏ RTSMRandomization and supply management
      • ³Ô¹Ï±¬ÁÏ Site ConnectAutomate information sharing
      • ³Ô¹Ï±¬ÁÏ Study TrainingStreamline and automate training
      • ³Ô¹Ï±¬ÁÏ DisclosuresCentralize clinical trial disclosures
      • ³Ô¹Ï±¬ÁÏ OpenData ClinicalProvide investigator and site data
      • Clinical Data
      • ³Ô¹Ï±¬ÁÏ EDCCollect and verify site data
      • ³Ô¹Ï±¬ÁÏ DQSAggregate and clean study data
      • ³Ô¹Ï±¬ÁÏ eCOACapture patient data
      • Patient Experience
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Regulatory Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ RIM
      • ³Ô¹Ï±¬ÁÏ RegistrationsTrack global registrations
      • ³Ô¹Ï±¬ÁÏ SubmissionsPlan and manage submissions
      • ³Ô¹Ï±¬ÁÏ Submissions PublishingPublish to health authorities
      • ³Ô¹Ï±¬ÁÏ Submissions ArchiveAccess submissions history
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Safety Solutions
      • ³Ô¹Ï±¬ÁÏ Development Cloud
      • ³Ô¹Ï±¬ÁÏ Safety Suite
      • ³Ô¹Ï±¬ÁÏ SafetyAdverse Event management
      • ³Ô¹Ï±¬ÁÏ SafetyDocsManage safety content
      • ³Ô¹Ï±¬ÁÏ Safety WorkbenchAdvanced reporting and analysis
      • ³Ô¹Ï±¬ÁÏ Safety SignalSignal detection and management
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Quality Solutions
      • ³Ô¹Ï±¬ÁÏ Quality Cloud
      • Quality Assurance
      • ³Ô¹Ï±¬ÁÏ QMSManage all quality processes in one place
      • ³Ô¹Ï±¬ÁÏ QualityDocsGain control of GxP documents
      • ³Ô¹Ï±¬ÁÏ Validation ManagementManage and execute paperless validation
      • ³Ô¹Ï±¬ÁÏ Batch ReleaseSpeed release decisions with confidence
      • ³Ô¹Ï±¬ÁÏ Product SurveillanceSimplify postmarket surveillance for medical devices
      • ³Ô¹Ï±¬ÁÏ Station ManagerDeliver right content to the right station
      • Training
      • ³Ô¹Ï±¬ÁÏ TrainingEnsure role-based qualification and compliance
      • Quality Control
      • ³Ô¹Ï±¬ÁÏ LIMSOptimize QC labs to increase efficiency
      • Health and Safety
      • ³Ô¹Ï±¬ÁÏ EHSManage environmental, health, and safety processes
      • Contract Services Organizations
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Medical Suite
      • ³Ô¹Ï±¬ÁÏ Medical Suite
      • Operations
      • ³Ô¹Ï±¬ÁÏ PublicationsPlan, author, and manage publications
      • ³Ô¹Ï±¬ÁÏ MedCommsCentralize and scale medical content
      • ³Ô¹Ï±¬ÁÏ MedInquiryStreamline inquiry intake and fulfillment
      • Engagement
      • Medical CRMDrive high-impact scientific exchange
      • ³Ô¹Ï±¬ÁÏ Link Key PeopleGet deep data on KOLs and their ecosystems
      • ³Ô¹Ï±¬ÁÏ Link WorkflowManage KOL engagement workflows
      • Insights
      • ³Ô¹Ï±¬ÁÏ Link Medical InsightsAccelerate insights from capture to action
      • Measuring Medical Impact
      • Reimagine Medical Engagement
      • Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Commercial Solutions
      • ³Ô¹Ï±¬ÁÏ Commercial Solutions
      • Commercial Evidence?Transform field and digital interactions into actionable insights
      • Software
      • CRM SuiteCoordinated agentic engagement across channels
      • Campaign ManagerSynchronized sales and marketing
      • Events ManagementLive, virtual, and hybrid events
      • AlignTerritory, roster, and engagement planning
      • Patient CRMPatient support and engagement
      • ContentCompliant content at scale
      • Marketing AnalyticsCampaign measurement, targeting, and insights
      • Data Science and Analytics PlatformIntegrated commercial data for faster insights
      • Network MDMStandardized master data management
      • Data
      • Global Reference DataComplete HCP and HCO profiles
      • Global HCP DataHCP access data
      • Global Deep DataKOL profiles and key account data
      • U.S. Performance DataHigh-quality patient, prescriber, and national data
      • Services
      • Business ConsultingStrategic advisory services
    • Data Solutions
      • ³Ô¹Ï±¬ÁÏ Data Cloud
      • Global Reference Data
      • ³Ô¹Ï±¬ÁÏ OpenData CommercialComplete HCP and HCO profiles
      • ³Ô¹Ï±¬ÁÏ OpenData ClinicalAccurate site and investigator data
      • Global HCP Data
      • ³Ô¹Ï±¬ÁÏ HCP AccessHCP access data
      • Global Deep Data
      • ³Ô¹Ï±¬ÁÏ Link Key PeopleDeep data on KOLs
      • ³Ô¹Ï±¬ÁÏ Link Key AccountsDeep data on key accounts
      • U.S. Performance Data
      • ³Ô¹Ï±¬ÁÏ Compass PatientAnonymous patient longitudinal data
      • ³Ô¹Ï±¬ÁÏ Compass PrescriberHCP, HCO, and ZIP projected data
      • ³Ô¹Ï±¬ÁÏ Compass NationalState and national projected data
      • Services
      • ³Ô¹Ï±¬ÁÏ AnalyticsStrategic advisory services
    • Vault AI
      • Vault AI
      • Vault AI
      • Agentic AIBuilt into Vault Platform
      • AI AgentsDeploy standard and custom agents
      • Vault Platform
    • Research Site Solutions
    • Industries
      • Industries
      • Pharma & BiotechR&D, quality, medical, and commercial solutions
      • Consumer HealthSolutions from clinical to commercial
      • Animal HealthTailored applications for animal health
      • MedTechStreamline content and data management
  • Services
    • Services
    • Business Consulting
    • Analytics
    • ³Ô¹Ï±¬ÁÏ Digital Events
    • Partners
    • Services Partners
    • Product Partners
    • AI Partners
    • Content Partners
    • CRO Partners
    • Data Partners
  • Customers
  • Resources
  • Events
  • About ³Ô¹Ï±¬ÁÏ
    • About ³Ô¹Ï±¬ÁÏ
    • Leadership
    • Public Benefit Corporation
    • Corporate Citizenship
    • Diversity at ³Ô¹Ï±¬ÁÏ
    • Partners
    • Trust
    • Recent University Graduates
    • News
    • Announcements
    • Press Coverage
    • ³Ô¹Ï±¬ÁÏ Blog
    • Contact Us
  • Contact Us
  • ³Ô¹Ï±¬ÁÏ Logo
  • ³Ô¹Ï±¬ÁÏ
      Clinical
      Regulatory
      Safety
      Quality
      Medical
      Commercial
      Data
      Vault AI
      Research Sites
      Industries
      Demo Center
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ Clinical Platform
      Clinical Operations
      ³Ô¹Ï±¬ÁÏ eTMF

      Stay inspection ready

      ³Ô¹Ï±¬ÁÏ CTMS

      Manage trials end-to-end

      ³Ô¹Ï±¬ÁÏ Payments

      Pay clinical research sites faster

      ³Ô¹Ï±¬ÁÏ Study Startup

      Accelerate site activation

      ³Ô¹Ï±¬ÁÏ RTSM

      Randomization and supply management

      ³Ô¹Ï±¬ÁÏ Site Connect

      Automate information sharing

      ³Ô¹Ï±¬ÁÏ Study Training

      Streamline and automate training

      ³Ô¹Ï±¬ÁÏ Disclosures

      Centralize clinical trial disclosures

      ³Ô¹Ï±¬ÁÏ OpenData Clinical

      Provide investigator and site data

      Clinical Data
      ³Ô¹Ï±¬ÁÏ EDC

      Collect and verify site data

      ³Ô¹Ï±¬ÁÏ DQS

      Aggregate and clean study data

      ³Ô¹Ï±¬ÁÏ eCOA

      Capture patient data

      Learn About the Patient Experience
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ RIM
      ³Ô¹Ï±¬ÁÏ Registrations

      Track global registrations

      ³Ô¹Ï±¬ÁÏ Submissions

      Plan and manage submissions

      ³Ô¹Ï±¬ÁÏ Submissions Publishing

      Publish to health authorities

      ³Ô¹Ï±¬ÁÏ Submissions Archive

      Access submissions history

      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA Development Cloud
      ³Ô¹Ï±¬ÁÏ Safety Suite
      ³Ô¹Ï±¬ÁÏ Safety

      Adverse Event management

      ³Ô¹Ï±¬ÁÏ SafetyDocs

      Manage safety content

      ³Ô¹Ï±¬ÁÏ Safety Workbench

      Advanced reporting and analysis

      ³Ô¹Ï±¬ÁÏ Safety Signal

      Signal detection and management

      Are you an emerging or clinical biotech? Learn More
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      Are you a CRO? Learn more
      VEEVA QUALITY CLOUD
      Quality Assurance
      ³Ô¹Ï±¬ÁÏ QMS

      Manage all quality processes in one place

      ³Ô¹Ï±¬ÁÏ QualityDocs

      Gain control of GxP documents

      ³Ô¹Ï±¬ÁÏ Validation Management

      Manage and execute paperless validation

      ³Ô¹Ï±¬ÁÏ Batch Release

      Speed release decisions with confidence

      ³Ô¹Ï±¬ÁÏ Product Surveillance

      Simplify postmarket surveillance for medical devices

      ³Ô¹Ï±¬ÁÏ Station Manager

      Deliver right content to the right station

      Training
      ³Ô¹Ï±¬ÁÏ Training

      Ensure role-based qualification and compliance

      Quality Control
      ³Ô¹Ï±¬ÁÏ LIMS

      Optimize QC labs to increase efficiency

      Health and Safety
      ³Ô¹Ï±¬ÁÏ EHS

      Manage environmental, health, and safety processes

      Are you a contract services organization? Learn More
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      ³Ô¹Ï±¬ÁÏ Medical Suite
      Operations
      ³Ô¹Ï±¬ÁÏ Publications

      Plan, author, and manage publications

      ³Ô¹Ï±¬ÁÏ MedComms

      Centralize and scale medical content

      ³Ô¹Ï±¬ÁÏ MedInquiry

      Streamline inquiry intake and fulfillment

      Insights
      ³Ô¹Ï±¬ÁÏ Link Medical Insights

      Accelerate insights from capture to action

      Engagement
      Medical CRM

      Drive high-impact scientific exchange

      ³Ô¹Ï±¬ÁÏ Link Key People

      Get deep data on KOLs and their ecosystems

      ³Ô¹Ï±¬ÁÏ Link Workflow

      Manage KOL engagement workflows

      Measuring Medical Impact
      Reimagine Medical Engagement
      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      ³Ô¹Ï±¬ÁÏ Connections Hub
      VEEVA COMMERCIAL SOLUTIONS
      Commercial Evidence™

      Transform field and digital interactions into actionable insights

      Software
      CRM Suite

      Coordinated agentic engagement across channels

      Campaign Manager

      Synchronized sales and marketing

      Events Management

      Live, virtual, and hybrid events

      Align

      Territory, roster, and engagement planning

      Patient CRM

      Patient support and engagement

      Content

      Compliant content at scale

      Marketing Analytics

      Campaign measurement, targeting, and insights

      Data Science and Analytics Platform

      Integrated commercial data for faster insights

      Network MDM

      Standardized master data management

      Data
      Global Reference Data

      Complete HCP and HCO profiles

      Global HCP Data

      HCP access data

      Global Deep Data

      KOL profiles and key account data

      U.S. Performance Data

      Patient and prescriber data

      Services
      Business Consulting

      Strategic advisory services


      By Need
      Achieve Agentic Commercial
      Increase Omnichannel Impact
      Agentic AI for MLR
       
      Segmentation & Targeting
      DTC Advertising
      Launch Excellence
      VEEVA DATA CLOUD
      Global Reference Data
      ³Ô¹Ï±¬ÁÏ OpenData Commercial

      Complete HCP and HCO profiles

      ³Ô¹Ï±¬ÁÏ OpenData Clinical

      Accurate site and investigator data

      Global HCP Data
      ³Ô¹Ï±¬ÁÏ HCP Access

      HCP access data

      Global Deep Data
      ³Ô¹Ï±¬ÁÏ Link Key People

      Deep data on KOLs

      ³Ô¹Ï±¬ÁÏ Link Key Accounts

      Deep data on key accounts

      U.S. Performance Data
      ³Ô¹Ï±¬ÁÏ Compass Patient

      Anonymous patient longitudinal data

      ³Ô¹Ï±¬ÁÏ Compass Prescriber

      HCP, HCO, and ZIP projected data

      ³Ô¹Ï±¬ÁÏ Compass National

      State and national projected data

      Services
      ³Ô¹Ï±¬ÁÏ Analytics

      Strategic advisory services


      By Need
      Achieve Agentic Commercial
      Deepen Your Customer Insights
      Tailor Content at Scale
       
      Increase Omnichannel Impact
      Drive Launch Excellence

      By Need
      Segmentation & Targeting
      FOR VAULT PLATFORM
      & VEEVA APPLICATIONS
      Vault AI
      Agentic AI

      Built into Vault Platform

      AI Agents

      Deploy standard and custom agents

      Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      Industries
      Pharma & Biotech

      R&D, quality, medical, and commercial solutions

      Consumer Health

      Solutions from clinical to commercial

      Animal Health

      Tailored applications for animal health

      MedTech

      Streamline content and data management

      Demo Center
      AI (³Ô¹Ï±¬ÁÏ AI)

      Clinical Operations

      Clinical Data

      Regulatory

      Safety

      Development Cloud

      Quality

      Commercial

      Medical

      Data

  • Services
      Services
      Business Consulting
      Analytics
      ³Ô¹Ï±¬ÁÏ Digital Events
      Partners
      Services Partners
      Product Partners
      AI Partners
      Content Partners
      CRO Partners
      Data Partners
  • Customers
  • Resources
  • Events
  • About ³Ô¹Ï±¬ÁÏ
      About ³Ô¹Ï±¬ÁÏ
      Leadership
      Public Benefit Corporation
      Corporate Citizenship
      Diversity at ³Ô¹Ï±¬ÁÏ
      Partners
      Trust
      Recent University Graduates
      News
      Announcements
      Press Coverage
      ³Ô¹Ï±¬ÁÏ Blog
      Contact Us
Industry Report

³Ô¹Ï±¬ÁÏ Pulse Field Trends Report Q2 2022

State of omnichannel field engagement.

Download PDF
Table of Contents

July 2022

State of Omnichannel Field Engagement

Each quarter, we¡¯ll provide unique insights into the most important global and regional trends for omnichannel field engagement, giving an exclusive view into when, where, and how field teams and healthcare professionals (HCPs) interact.

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report reflects data and insights from field engagement activities of more than 80% of all industry representatives worldwide.1 ³Ô¹Ï±¬ÁÏ CRM Standard Metrics ¨C now used industrywide ¨C provides the basis for consistent collection and measurement of engagement KPIs such as channel mix and productivity across regions, roles, and market segments.

With these insights, you can now benchmark performance and set the right actionable goals. For example, video calls deliver three times greater promotional response from HCPs versus in-person meetings alone and leaders are gaining an advantage by using video calls three times weekly.

For Boehringer Ingelheim, ³Ô¹Ï±¬ÁÏ Pulse Insights ¡°bring an additional level of clarity that strengthens the way we make informed decisions,¡± says BI¡¯s head of customer-facing execution excellence, Carol-Ann Krupka.

Given the rapidly evolving state of customer engagement, I¡¯m excited to be able to share these valuable insights with you every quarter.

Looking forward to continuing to innovate together to achieve true commercial excellence.

Thank you,

Dan Rizzo
Vice President, Business Consulting, ³Ô¹Ï±¬ÁÏ


VEEVA PULSE INSIGHT:

Video Calls 3x More Effective,
Leaders Gain Advantage Using Them 3 Times Week

When it began, the pandemic forced nearly all engagement online. As restrictions give way to more in-person opportunities, new Pulse Insights reveal there¡¯s now a 70/30 mix of in-person to virtual engagement (video, chat or text, phone, and email).

Data show the companies making widespread investments in omnichannel engagement ¨C that fully leverage digital and in-person ¨C are seeing the greatest improvements in efficiency, customer experience, and customer access. And 75% of HCPs2 report they want to keep or increase digital interactions with reps.

The use of video meetings in conjunction with in-person meetings increases efficiency and impact. When engaging HCPs through a blend of in-person and virtual channels, such as ³Ô¹Ï±¬ÁÏ CRM Engage, video engagement has three times the promotional response compared to in-person meetings alone, offering a significant advantage (see Figure 5).3

HCP ENGAGEMENT TRENDS IN 2022

75%

HCPs want to keep or increase digital interactions2

3x

Greater promotional response from video meetings when combined with in-person3

3x

Leaders average up to three video meetings per week

Virtual engagement is a natural complement and accelerator to in-person and has tremendous benefits to the customer experience. As ³Ô¹Ï±¬ÁÏ Pulse data show, the top three leading U.S. oncology franchises use video meetings 2.5 times more, use content twice as much, and have 67% longer meetings compared to their peers (see Figure 1). Importantly, they use these meetings to complement in-person selling efforts, extending the conversation and deepening relationships with digital touchpoints between in-person meetings.

FIGURE 1: VIRTUAL ENGAGEMENT IN ONCOLOGY

LEADING ONCOLOGY (TOP 3)

TOP 20 ONCOLOGY

Using newer channels like chat and text, as well as expanding the use of video and email, some companies are realizing the benefit of ¡°pull¡± models where HCPs reach out directly for information alongside their traditional ¡°push¡± outreach tactics. This model allows HCPs to engage via their preferred channels at times that are most convenient, for more in-depth conversations with the representatives they trust.

Companies leading in omnichannel engagement have established a platform for this ¡°pull¡± model where HCPs can engage in two-way communication as a key part of the mix. These reps are top of mind and easy to reach when HCPs need information, samples, or to schedule a virtual or live meeting.

As a result, three distinct levels of rep engagement have emerged, with significant impact on access, brand perception, and engagement. At baseline, reps are back in-person, building HCP relationships. At the next level, reps also use HCPs¡¯ preferred channels to establish in-depth, trusted touchpoints. But the very best reps build deep in-person and digital connections that ensure they are sought after and easy to reach, even when they¡¯re not physically present. In effect, the best reps never leave the room.

Omnichannel excellence means the best rep never leaves the room
VEEVA PULSE INSIGHT:

Digital Trends

1. The return of in-person, and greater expectations from HCPs

After COVID-19 forced companies to shift to a new digital engagement model overnight, a question remained: will the industry eventually return to an in-person status quo, or will a new blended model emerge? ³Ô¹Ï±¬ÁÏ Pulse data show in-person now accounts for roughly 70% of HCP interactions globally from April to June 2022 (Figure 2). Although in-person is again the predominant channel, now that 75% of HCPs expect a blend of digital engagement, field teams are evolving to a new omnichannel model.4

FIGURE 2: GLOBAL CHANNEL MIX

The channel mix and rate of return to in-person have not been the same everywhere. For example, the U.K. is an outlier among major markets, with significantly lower activity across all channels. The U.K. has one of the lowest rates of HCP touchpoints at roughly 21 per user per week, of which only 32% are in-person, and 43% are email (Figure 3).

FIGURE 3: U.K. CHANNEL MIX COMPARED TO MAJOR MARKETS

2. Leaders leverage video calls for richer and more frequent engagement

When engaging HCPs through a blend of in-person and virtual channels, CRM Engage video meetings have three times the promotional response compared to in-person meetings alone, offering a significant advantage (Figure 5). In addition to extending the conversation beyond face-to-face, replacing phone calls with video meetings delivers a richer experience and greater message delivery thanks to content and other visual aids. When engaging HCPs through a blend of in-person and virtual channels, video meetings have three times the promotional response compared to in-person meetings alone, offering a significant advantage.

FIGURE 4: WEEKLY VIRTUAL MEETING USAGE ACROSS COMPANIES

FIGURE 5: PROMOTIONAL RESPONSE COEFFICIENT

ACTION

Given HCPs want more digital engagement, video calls increase promotional response 3x, and leaders are gaining greater mindshare using video calls 3x a week ¨C ensure your mix and frequency maximize the opportunity. Tailor field coaching and training to establish strong video engagement behaviors.

3. Capitalizing on content with the right platform

Content is still king. The fundamental drivers of promotional response continue to be time with the customer and content utilization. Although content usage in video meetings is consistently higher than in-person, it can differ depending upon the platform. For example, content usage is approximately 85% globally via ³Ô¹Ï±¬ÁÏ CRM Engage meetings, compared to approximately 40% for other video platforms (Figure 6). In addition, CRM Engage meeting duration averages 21 minutes globally, which is four- to five-times longer than a typical in-person meeting and creates more opportunities to share content.

FIGURE 6: WEEKLY CONTENT USAGE BY CHANNEL

ACTION

Is your content library robust enough to get the most out of your content during video calls? And how can you drive higher content utilization during in-person meetings? Ensure you have a fine-tuned content supply chain and operating model, effective platforms for delivering content to customers, a modular content strategy, and field force training on the role content plays in driving treatment starts.

Conclusion

The way pharma field teams engage with HCPs is shifting once again. Success hinges on empowering field teams with data-driven insights to build the best omnichannel mix that engages HCPs when and where they need it most.

³Ô¹Ï±¬ÁÏ Pulse Field Trends Reports, created with data and insights from field engagement activities of more than 80% of all industry representatives worldwide, provide unique insights into HCP engagement to benchmark against industry leaders and set actionable goals to achieve commercial excellence.


VEEVA PULSE INSIGHT:

Global and Regional Views

Global trends

  1. Physician access returned, and the industry has prioritized getting back in front of customers. Globally, in-person remains the dominant channel for HCP engagement, representing roughly 70% of activity in 2Q22 (Figure 8).
  2. There are clear differences in the level and type of engagement between sales, key account management (KAM), and field medical teams. As expected, volumes per user are lower with field medical, and they deliver the highest number of video calls at 1.8 per user per week globally (Figure 10).
  3. Content usage in video engagement has remained relatively consistent over time; however, we see a substantial difference in the proportion of video calls with tracked content among various technology platforms. Tracked content usage through ³Ô¹Ï±¬ÁÏ CRM Engage sits at approximately 85% compared to 40% when looking at video calls on other platforms (Figure 13).

FIGURE 7: CHANNEL MIX EVOLUTION

FIGURE 8: CHANNEL MIX

Global Field Team Activity
Weekly Activity Per User by Engagement Channel


FIGURE 9: BY REGION

FIGURE 10: BY USER TYPE

FIGURE 11: BY COMPANY SIZE

Global Engagement Quality
Consolidation of Key Quality Metrics


FIGURE 12: TRENDING VEEVA CRM APPROVED EMAIL VOLUME
VS OPEN RATE AND CLICK RATE

FIGURE 13: TRENDING CONTENT USAGE BY CHANNEL

FIGURE 14: ENGAGE MEETING DURATION

U.S. market trends

  1. The total volume of interactions gradually decreased over the two-month period across the U.S. During this period, in-person engagement, which contributed 71% of activity in April, fell to 68% in June. Over the same period, combined video and email channels increased from approximately 20% to 24% of the channel mix (see Figure 15).
  2. The volume of delivered ³Ô¹Ï±¬ÁÏ CRM Approved Email remained consistent throughout the quarter at approximately 300K weekly; however, open rates consistently declined by 5% during the period, ending at 30% by the end of June (see Figure 20).
  3. Content utilization via virtual meetings with ³Ô¹Ï±¬ÁÏ CRM Engage is consistent at approximately 80%, with meetings lasting 21 minutes.

FIGURE 15: CHANNEL MIX EVOLUTION, U.S.

FIGURE 16: CHANNEL MIX, U.S.

U.S. Field Team Activity
Weekly Activity Per User by Engagement Channel


FIGURE 17: TRENDING PRODUCTIVITY, U.S.

FIGURE 18: BY USER TYPE

FIGURE 19: BY COMPANY SIZE

U.S. Engagement Quality
Consolidation of Key Quality Metrics


FIGURE 20: TRENDING APPROVED EMAIL VOLUME
VS. OPEN AND CLICK RATE, U.S.

FIGURE 21: TRENDING CONTENT USAGE BY CHANNEL, U.S.

FIGURE 22: ENGAGE MEETING DURATION, U.S.

Europe market trends

  1. In-person engagement is consistent at approximately 60% of the channel mix, with email the second largest channel by volume at 30%. (See Figure 23).
  2. ³Ô¹Ï±¬ÁÏ CRM users in Spain recorded the highest volume of interactions per user than in any other EU5 (France, Germany, Italy, Spain, United Kingdom) market by a large margin, with >46 in-person HCP interactions per week (see Figure 25).
  3. ³Ô¹Ï±¬ÁÏ CRM users in the U.K. recorded the lowest number of HCP touchpoints with 7 in-person interactions per week. In-person access has not returned in the U.K. to the same degree as in other European markets (see Figure 26).

FIGURE 23: CHANNEL MIX EVOLUTION, EUROPE

FIGURE 24: CHANNEL MIX, EUROPE

Europe Field Team Activity
Weekly Activity Per User by Engagement Channel


FIGURE 25: BY COUNTRY IN EUROPE

FIGURE 26: BY USER TYPE

FIGURE 27: BY COMPANY SIZE

Europe Engagement Quality
Consolidation of Key Quality Metrics


FIGURE 28: TRENDING APPROVED EMAIL VOLUME
VS. OPEN AND CLICK RATE, EUROPE

FIGURE 29: TRENDING CONTENT USAGE BY CHANNEL, EUROPE

FIGURE 30: ENGAGE MEETING DURATION, EUROPE

Asia Pacific market trends

  1. In-person engagement consistently makes up 70% to 75% of the channel mix in the Asia Pacific region (see Figure 32).
  2. Sales users in Asia Pacific are nearly twice as productive compared to KAMs, and three times as productive compared to medical users with about 66 touchpoints per week (see Figure 34). KAMs use the phone channel significantly more than sales and medical users.
  3. Content utilization in the Asia Pacific region is exceptionally high, with approximately 95% of virtual meetings on ³Ô¹Ï±¬ÁÏ CRM Engage, 75% of video engagements, and 55% of in-person engagements leveraging content. This usage is greater than any other major region in each of the three channels (see Figure 37).

FIGURE 31: CHANNEL MIX EVOLUTION, ASIA PACIFIC

FIGURE 32: CHANNEL MIX, ASIA PACIFIC

Asia Pacific Field Team Activity
Weekly Activity Per User by Engagement Channel


FIGURE 33: BY COUNTRY IN ASIA PACIFIC REGION

FIGURE 34: BY USER TYPE

FIGURE 35: BY COMPANY SIZE

Asia Pacific Engagement Quality
Consolidation of Key Quality Metrics


FIGURE 36: TRENDING APPROVED EMAIL VOLUME
VS. OPEN AND CLICK RATE, ASIA PACIFIC

FIGURE 37: TRENDING CONTENT USAGE BY CHANNEL, ASIA PACIFIC

FIGURE 38: ENGAGE MEETING DURATION, ASIA PACIFIC

Latin America market trends

  1. In Latin America (Brazil, Columbia, Ecuador, Mexico, Peru), CRM activity volume has been steady throughout 2Q22, with in-person engagement making up approximately 70% of the overall channel mix (See Figure 39). Latin America is unique in its use of chat or text calls, which consistently make up 2% to 3% of the channel mix.
  2. Ecuador, Mexico, and Peru have notably higher average weekly total user productivity than Brazil and Colombia. This difference is driven by in-person engagement, with 47 in-person touchpoints per week in Ecuador versus 29 in-person touchpoints in Colombia (see Figure 41).
  3. The volume of delivered ³Ô¹Ï±¬ÁÏ CRM Approved Emails remained consistent throughout the quarter; however, open rates consistently declined by approximately 5% during the period, ending at 42% by the end of June (see Figure 44).

FIGURE 39: CHANNEL MIX EVOLUTION, LATIN AMERICA

FIGURE 40: CHANNEL MIX, LATIN AMERICA

Latin Amercia Field Team Activity
Weekly Activity Per User by Engagement Channel


FIGURE 41: BY COUNTRY IN LATIN AMERICA REGION

FIGURE 42: BY USER TYPE

FIGURE 43: BY COMPANY SIZE

Latin America Engagement Quality
Consolidation of Key Quality Metrics


FIGURE 44: TRENDING APPROVED EMAIL VOLUME
VS. OPEN AND CLICK RATE, LATIN AMERICA

FIGURE 45: TRENDING CONTENT USAGE BY CHANNEL, LATIN AMERICA

FIGURE 46: ENGAGE MEETING DURATION, LATIN AMERICA


Appendix: Data Dictionary

Metric Definitions

  • Channel Mix Evolution Over Time: Weekly ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat or text)
  • Q2 Channel Mix: Total ³Ô¹Ï±¬ÁÏ CRM activity volume for 2Q22 broken down by engagement channel percentage
  • Weekly Activities Per User: The average weekly number of ³Ô¹Ï±¬ÁÏ CRM activities submitted per number of users active in ³Ô¹Ï±¬ÁÏ CRM
  • Trending Approved Email Volume: Volume of approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email Open Rate: Percentage of approved emails opened at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email Click Rate: Percentage of approved emails clicked at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • In-Person % Content Usage: Percentage of in-person engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Video % Content Usage: Percentage of video engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Engage Meeting % Content Usage: Percentage of Engage meetings that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Engage Meeting Duration: The average duration of Engage meetings in minutes

Engagement Channel Definitions

  • In-Person: Submitted Calls with a CRM Standard Metrics Call Channel value of ¡®In-Person¡¯
  • Phone: Submitted Calls with a CRM Standard Metrics Call Channel value of ¡®Phone¡¯
  • Video: ³Ô¹Ï±¬ÁÏ Engage Calls and Video Calls via other platforms that are then recorded as Calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics Call Channel value of ¡®Video¡¯
  • Email: Approved Emails and Emails sent via other platforms that are then recorded as Calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics Call Channel value of ¡®Email¡¯
  • Chat or Text: Submitted Calls with a CRM Standard Metrics Call Channel value of ¡®Chat or Text¡¯

User Type Definitions

  • Sales: Users that have been classified with the ¡®Sales¡¯ value in the CRM Standard Metrics ¡®User Type¡¯ field
  • Key Account Manager: Users that have been classified with the ¡®Key Account Manager¡¯ value in the CRM Standard Metrics ¡®User Type¡¯ field
  • Medical: Users that have been classified with the ¡®Medical¡¯ value in the CRM Standard Metrics ¡®User Type¡¯ field

Company Size Definitions

  • Top Global Pharma: ³Ô¹Ï±¬ÁÏ CRM customers included in the Top 17 Pharma Companies based on Global Revenue
  • Rest of Industry: All other ³Ô¹Ï±¬ÁÏ CRM customers

1 ³Ô¹Ï±¬ÁÏ Pulse Data, July 2022
2 , BCG, September 2021
3 ³Ô¹Ï±¬ÁÏ Pulse and ³Ô¹Ï±¬ÁÏ Data Cloud, January 2019¨CSeptember 2021
4 BCG, September 2021
Let's Partner

Interested in learning more about
how ³Ô¹Ï±¬ÁÏ can help?

Contact Us Download PDF
Join the Conversation in ³Ô¹Ï±¬ÁÏ Connect

Where customers and ³Ô¹Ï±¬ÁÏ product leaders share information and ideas

³Ô¹Ï±¬ÁÏ Logo

Software, AI, Data, and Consulting for the Global Life Sciences Industry

? Copyright 2026 ³Ô¹Ï±¬ÁÏ Systems

Global Headquarters

Follow Us on Social

Demo Center Contact ³Ô¹Ï±¬ÁÏ

Solutions

  • Clinical
  • Regulatory
  • Safety
  • Quality
  • Medical
  • Commercial
  • Industry Segments

Services

  • Business Consulting

Partners

  • Service Partners
  • Product Partners
  • AI Partners
  • Content Partners
  • CRO Partners
  • Data Partners

Resources

  • Customer Stories
  • Resource Center
  • Events
  • News & Press
  • Blog

About ³Ô¹Ï±¬ÁÏ

  • Leadership
  • Public Benefit Corporation
  • Corporate Citizenship
  • Diversity at ³Ô¹Ï±¬ÁÏ
  • Trust

Global Headquarters

Follow Us on Social

Do Not Sell or Share My Personal Information Privacy Notice Terms Site Map